With 1.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.51 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $331.07 whereas the lowest price it dropped to was $322.21. The 52-week range on CI shows that it touched its highest point at $370.83 and its lowest point at $253.95 during that stretch. It currently has a 1-year price target of $398.55. With its current market cap of 91.81 billion, CI has annualized dividend of $5.43 while the current yield stands at 1.65%. Beta for the stock currently stands at 0.50.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CI was up-trending over the past week, with a rise of 1.91%, but this was up by 3.94% over a month. Three-month performance dropped to -6.76% while six-month performance fell -2.30%. The stock gained 15.21% in the past year, while it has gained 10.23% so far this year. A look at the trailing 12-month EPS for CI yields 10.60 with Next year EPS estimates of 31.54. For the next quarter, that number is 7.83. This implies an EPS growth rate of 13.60% for this year and 10.67% for next year. EPS is expected to grow by 11.50% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 10.54%.
Float and Shares Shorts:
At present, 292.50 million CI shares are outstanding with a float of 272.90 million shares on hand for trading. On 2024-10-31, short shares totaled 3.45 million, which was 124.0 higher than short shares on 1727654400. In addition to Mr. David Michael Cordani as the firm’s President, CEO & Chair of the Board, Mr. Brian C. Evanko C.F.A. serves as its Executive VP, CFO and President & CEO for Cigna Healthcare.
Institutional Ownership:
Through their ownership of 0.89726996 of CI’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CI since 26 analysts follow the stock currently. There are 21 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 5 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CI analysts setting a high price target of 438.0 and a low target of 360.0, the average target price over the next 12 months is 399.00293. Based on these targets, CI could surge 32.7% to reach the target high and rise by 9.07% to reach the target low. Reaching the average price target will result in a growth of 20.88% from current levels.
Analysts have provided yearly estimates in a range of $28.80146 being high and $28.40143 being low. For CI, this leads to a yearly average estimate of $28.50144.
